Product
Standardized Regimen
1 clinical trial
2 indications
Indication
TuberculosisIndication
PulmonaryClinical trial
Efficacy and Safety of Short-course Treatment for Drug-sensitive Tuberculosis in ChinaStatus: Recruiting, Estimated PCD: 2024-10-01